Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.
about
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathyEculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate.An international consensus approach to the management of atypical hemolytic uremic syndrome in children.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Eculizumab in Transplant-Associated Thrombotic Microangiopathy.Novel immunosuppressive agents in kidney transplantationTherapeutic apheresis for patients with cancer.Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.Eculizumab Treatment in a Patient with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy and Steroid-Refractory Acute Graft Versus Host Disease.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Renal and neurological response with eculizumab in a patient with transplant associated thrombotic microangiopathy after allogeneic hematopoietic progenitor cell transplantationMultiple Myeloma as the Underlying Cause of Thrombotic Microangiopathy Leading to Acute Kidney Injury: Revisiting a Very Rare Entity.No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab.
P2860
Q30276550-99F491AD-B5A4-4961-8326-79776845F0FCQ33407913-7894DCD2-F6F0-4E72-927D-C512010248DFQ33408788-D1294B0C-ED0E-4625-82E6-F9B1E532D50DQ33412325-8567101F-D9D1-4778-8404-A98125355166Q33417613-8AF02275-02C4-405D-98A7-E8CEE740BC0FQ33419794-C95375EE-E829-49EB-BEDD-9003DD41F14CQ33421861-90A14F49-D33D-42E9-9710-08932C5FCEE8Q33424902-A4B48251-E59F-45D1-A671-9CA5F41CF659Q33425079-BB773926-47E1-42E5-9F10-8DF3380AF335Q38176005-EB8A221F-7582-438B-99BA-E679B166E6F8Q38287610-782A6E05-B1C3-4915-8FB3-3A2D1E5F2573Q39968188-09D2D660-8A44-44A9-AD22-51326D92318CQ40096407-69662D4C-F944-48AD-9688-86DFFB87F13FQ41146886-3B5123BE-0E18-4951-AB6B-FA1EC50ED349Q41992358-C6EA76F6-69E0-4A47-B472-40B05C840C34Q42063587-91818314-09A0-450C-B004-095BD9348922Q42086661-0A35E3B6-F819-4909-B616-F3ACF8E7B4DFQ42200268-46CD8F65-3F8E-4839-A511-DE6534CE3271Q42364066-297081DB-0D56-4EF3-8008-EDF661AC084CQ50025315-5B0B5A58-5609-4FCE-B682-90960642B9B3
P2860
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Successful use of eculizumab i ...... nt thrombotic microangiopathy.
@en
Successful use of eculizumab i ...... nt thrombotic microangiopathy.
@nl
type
label
Successful use of eculizumab i ...... nt thrombotic microangiopathy.
@en
Successful use of eculizumab i ...... nt thrombotic microangiopathy.
@nl
prefLabel
Successful use of eculizumab i ...... nt thrombotic microangiopathy.
@en
Successful use of eculizumab i ...... nt thrombotic microangiopathy.
@nl
P2093
P2860
P356
P1476
Successful use of eculizumab i ...... nt thrombotic microangiopathy.
@en
P2093
Aliénor Xhaard
Anne Marie Fischer
Dominique Helley
Paul Coppo
Véronique Fremeaux-Bacchi
P2860
P304
P356
10.1111/BJH.12202
P407
P577
2013-01-07T00:00:00Z